A New York-based biotech holding company focused on investing in and developing solutions for anti-aging through epigenetic reprogramming and other methods.
At the heart of our mission lies a bold vision: to transform health and wellness as we know it. With our groundbreaking technology, we’re not just innovating – we’re revolutionizing. By harnessing the extraordinary power of embryonic and placental genes, alongside the body’s natural healing mechanisms, we’re on a mission to breathe new life into aging cells.
Since 2014, the Hebrew University of Jerusalem has studied and developed a unique patented set of factors/genes that can rejuvenate cells, which are believed to be superior to those of our competitors. Prof. Yosef Buganim, a world leader in the field of stem cells and reprogramming, was the first to discover a combination of genes that can convert adult cells into placental stem cells. Given that the chronological age of the placenta is zero (embryonic stage), Prof. Buganim’s method can also rejuvenate cells through site-specific alteration of epigenetic marks.
His research demonstrated that this combination of factors is particularly potent in targeting the genome of adult cells, achieving up to 50% age reversal in adult skin cells while preserving their identity. This age reversal was associated with improved function and healthier cells. Moreover, unlike Yamanaka factors, which carry a tumorigenic risk (formation of teratoma, a benign tumor), Prof. Buganim’s combination is safer.
Every adult will be eligible to receive our affordable therapy for age related disease as well as preventive treatment for immune system rejuvenation, keeping them healthy until a very old age.
Ananda Labs is dedicated to improving the lives of people. Our passionate team tackles challenging research to make a significant impact. If you’re driven by innovation, consider joining us.
Request password by email: info@ananda-labs.com
